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SEMINAR PAPERS
The use of endoscopy in liver diseases
GKK Lau, M Ng, WHC Wu, SK Lam
The use of fibre-optic endoscopy has greatly facilitated the management of some patients with chronic
liver disease. Upper endoscopy plays a pivotal role in the diagnosis and management of oesophageal and
gastric varices. With the use of reflectance septrophotometry, gastroduodenal mucosal haemoglobin
concentration and oxygen saturation can be more precisely measured. Recently, it has been shown that
acute gastroduodenitis is associated with a lower pre-treatment mucosal oxygen concentration in the
antrum and the first part of the duodenum. Endoscopic ultrasound is increasingly being used to detect
varices and in the staging of gastrointestinal tumours. Endoscopic retrograde cholangiopancreatography
plays an important role in the diagnosis of recurrent pyogenic cholangitis and endoscopic sphincterotomy
is a useful form of treatment. Laparoscopy, with the aid of ultrasound and biopsy is helpful in staging
chronic liver disease, identifying focal lesions, and diagnosing peritoneal disease.
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Introduction
Endoscopy, principally flexible endoscopy of the
gastrointestinal tract and diagnostic laparoscopy, is
increasingly being used in the investigation and
management of liver diseases. Progress in instru-
mentation and active clinical research continue to
expand the potential clinical utility of endoscopic
ultrasound (EUS). It is the purpose of this article to
review the role of upper gastrointestinal endoscopy,
endoscopic ultrasound, endoscopic retrograde cho-
langiopancreatography (ERCP), and laparoscopy in
hepatology.
Upper gastrointestinal endoscopy
Oesophageal varices
Oesophageal varices are dilated collaterals in the lower
oesophagus that interconnect portal and systemic
circulation in patients with portal hypertension.
Endoscopically, oesophageal varices are usually
unmistakable and appear as irregular, serpiginous,
bluish structures running longitudinally in the sub-
mucosa of the oesophageal wall (Fig 1). Occasionally,
it can be difficult to differentiate small varices from
oesophageal folds and EUS can be helpful. The
presence of varices in patients with cirrhosis is also
an independent risk factor for survival.1
The appearance of oesophageal varices is not diag-
nostic of the cause of portal hypertension and does not
allow differentiation between portal hypertension second-
ary to cirrhosis, pre-sinusoidal hypertension, or portal or
splenic vein thrombosis. The majority of patients with
cirrhosis develop varices and approximately one third
bleed at some point.2 The mortality from this first bleed
is approximately 30% to 50% and two thirds of these
patients die within one year.3 With this high mortality
associated with bleeding, prophylactic measures have
been vigorously pursued. To this end, prophylactic shunt
surgery and sclerotherapy have not been shown to be of
benefit and banding ligation is as yet untested.
As only one third of patients will bleed, the accu-
rate targeting of those at risk is important. The most
popular model used is that devised by the North
Italian Endoscopic Club for the Study and Treatment
of Oesophageal Varices.4 The severity of the underly-
ing liver disease, the presence or absence of red mark-
ings on the varices, and the size of the varices are the
most important risk factors for bleeding.
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Emergency endoscopy is the key investigation in
the management of oesophageal variceal bleeding.
It serves to confirm that the bleeding is from the
oesophageal varices and to exclude other causes of up-
per gastrointestinal bleeding. Emergency endoscopic
sclerotherapy5-8 stops active bleeding effectively and
prevents early re-bleeding. Long term treatment with
repeat sessions of sclerotherapy also significantly de-
creases re-bleeding and there are some reports that it
leads to improved survival.9-12 The sclerosants most
commonly employed include sodium morrhuate
(5% solution), sodium tetradecylsulfate (STS, 1%
or 3% solution), ethanolamine oleate and polidocanol.
All of these may be injected into or around the oesopha-
geal varices with the exception of polidocanol, which
should not be injected intravenously and is usually in-
jected into the paravariceal tissue. However, re-bleeding
is still common in patients receiving sclerotherapy
and complications can arise after it. These include
retrosternal pain, fever, oesophageal ulceration, sympa-
thetic pleural effusion, oesophageal perforation, media-
stinitis, and venous embolization of sclerosant, or in-
fection. Surgery11,12 or transjugular intrahepatic
portosystemic shunts (TIPS)13 should be considered if
more than two injection sessions are required to stop
the bleeding.
Endoscopic ligation was developed in an attempt to
provide an endoscopic therapy that would be at least
as effective as sclerotherapy but would have fewer
complications.14-16 It involves placing pre-stretched rub-
ber bands on variceal columns, using a delivery device
mounted at the end of an endoscope. The oesophageal
mucosa and submucosa, containing varices, are ensnared,
causing subsequent strangulation, sloughing, and even-
tual fibrosis, and resulting in the obliteration of the
varices.14-16 Randomised trials comparing endoscopic
variceal ligation with sclerotherapy suggest that ligation
is at least as effective as sclerotherapy.1 7-19 In a recent
meta-analysis, endoscopic ligation, when compared with
endoscopic sclerotherapy, was shown to have a lower re-
bleeding rate, mortality rate, rate of death due to
bleeding, and oesophageal stricture rate.20 The use of
intravenous octreotide with endoscopic ligation might
further decrease the re-bleeding rate.21 The major disad-
vantage of endoscopic ligation is the need for an over-
tube, which decreases the endoscopic field of view and
may allow pooling of blood. These can be partially cir-
cumvented by using newly modified banding devices such
as the multiple band ligator (Microvasive, Boston Scien-
tific Corporation, Watertown, Ma, US) [Fig 2].
Gastric varices
Gastric varices are submucosal structures that can have
a mottled appearance or even resemble clusters of
grapes (Fig 3).22 The bluish colour that is characteristic
of oesophageal varices is usually absent in the stomach.
Gastric varices may be confused with enlarged folds,
except when they run perpendicularly to the axes of
the folds. Isolated gastric varices may develop as a
consequence of pancreatic disorders that obstruct the
splenic vein. Much confusion about the grading and
classification of gastric varices exists because of the
multiplicity of schemes that have been suggested.23 The
most commonly used classification recognises three
Fig 2. Application of multiple band ligator to
oesophageal varices
Fig 1. Oesophageal varices identified endoscopically
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types of gastric varices. These include possible varices
where there is doubt regarding their differentiation
from folds, cardial oesophageal varices or cardial
varices in continuity with oesophageal varices, and true
gastric varices that are localised in the fundus and/or
the cardial area and may extend to the body.
The importance of red colour signs on gastric
varices is controversial. The disagreement is over
whether these colour signs are related to the varix or
to the overlying portal hypertensive gastropathy. Some
reports have previously suggested that red spots on
gastric varices are risk factors for haemorrhage.24
The rationale for devising a classification was to
offer guidance on treatment. Type 1 varices should
respond successfully to standard sclerotherapy or
banding. Type 2 varices require either specialist
endoscopic techniques such as the application of tissue
adhesive (e.g. n-butyl-2-cyanoacrylate) [Histocryl],
thrombin injection, decompression by surgery, or per-
formance of TIPS. Gastric varices are believed to be
much less common than oesophageal varices; the re-
ported incidence of gastric varices varies from 6% to
100%.25 Approximately 75% of gastric varices occur
along the lesser curve of the stomach and only 9% are
localised to the fundus.26
Ectopic varices
The prevalence of ectopic varices in cirrhotic patients
ranges from 1% to 5%. Ectopic varices are predominantly
located in the digestive tract.27 Much less frequently,
they occur in the peritoneum, biliary tract, vagina, and
the bladder (Table). These often have a grape-like
appearance. Sometimes, they appear as tumours and if
biopsied, could lead to fatal torrential bleeding. In
patients who have had an ileostomy or colostomy and
have portal hypertension, ectopic varices might develop
near the stoma site due to the presence of a porto-
systemic connection.28 Such varices can easily be
inspected by the gentle passage of a narrow endoscope
a few centimetres into the stoma.
Previous abdominal surgery is also a risk factor for
the development of ectopic varices as the adhesions
act as variceal conduits. With enteroscopy, jejunal and
ileal varices can now be diagnosed directly rather
than by angiographic studies. The incidence of colonic
varices is unaffected by the type of portal hypertension
Fig 3. Grape-like bunches of gastric varices at the
cardia
Table. Distribution of bleeding varices as reported
in the literature27
Sites of ectopic varices Percentage of total
Duodenum 17
Jejunum and ileum 18
Colon 15
Rectum 9
Ileostomy or colostomy site 27
Peritoneum 10
Common bile duct and gallbladder 2
Vagina <1
Bladder <1
Fig 4. Acute gastroduodenitis after transcatheter
oily chemoembolization
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but they are more common in patients who have had
previous surgery. Differentiation between varices
and tumours is more of a problem in the colon because
tumours are not uncommon here. In patients with
suspected portal hypertension, any suspicious lesion
without definitive evidence of malignancy should only
be biopsied following angiographic studies to exclude
varices.
Rectal varices are true variceal vessels that occur
in the walls of the rectum above the anus. Bleeding
rectal varices are uncommon but can on occasion be
exsanguinating.29 Either rigid or flexible sigmoidos-
copy allows the diagnosis to be made with ease and it
should be remembered that balloon tamponade in the
rectum is as effective as it is in the oesophagus.
Portal hypertensive enteropathy
Portal hypertension affects the gastrointestinal tract and
it may lead to portal hypertensive gastropathy (PHG)
and portal hypertensive colopathy. The former condi-
tion was first described by Osler30 as chronic gastritis
associated with cirrhosis and later redefined by
McCormack31 as a vascular disorder rather than inflam-
matory condition. It is the cause of chronic anaemia in
some cirrhotic patients and can be classified into two
main types.23 Type I typically has a mosaic-like pat-
tern of small polygonal areas that slightly protrude in
the centre surrounded by a whitish or yellow depressed
border. The mosaic-like pattern can be mild with a dif-
fusely pink areola, moderate with a flat red spot in the
centre of the pink areola or severe, with a diffusely red
areola. Type II produces mucosal red marks. These can
occur in isolation or in association with the mosaic-
like pattern.They are red lesions of variable diameter
and are either flat or slightly protruding into the
lumen of the stomach. The lesions can be diffuse,
discrete, or confluent. Black or brown spots are not
diagnostic of PHG, but are indicative of recent bleed-
ing. Type I is the more common of the two types
and is unlikely to be associated with gastrointestinal
haemorrhage and can occur in the absence of portal
hypertension, particularly the mild form. Type II is
much less common and can cause chronic intestinal
blood loss. It appears to be much more specific as a marker
of PHG.
The pathogenesis of PHG is unclear, although the
presence of portal hypertension is important.32 It is not
the only factor, however, as there is no relationship
between the degree of portal pressure and the pres-
ence or absence of PHG.33 Portocaval shunt surgery
cures PHG but propanolol has been shown to be highly
effective in controlling bleeding from this condition
and should now be considered the treatment of choice.34
Other factors, such as the presence of Helicobacter
pylori infection,35 do not appear to be important.
Portal hypertensive colopathy is present in approxi-
mately 70% of patients with portal hypertension. Colono-
scopy reveals vascular ectasias, irregularity, dilatation,
solitary red spots, diffuse red spots, and haemorrhoids.
Patients with portal hypertensive colopathy more
frequently have oesophageal varices and PHG.34
Post-transcatheter oily chemoembolization
gastroduodenitis
Transcatheter oily chemoembolization (TOCE) has
been used to treat hepatocellular carcinoma (HCC).36
In a recent prospective study, the effect of TOCE
on the gastroduodenal microcirculation and the
relationship between pre-TOCE gastroduodenal
microcirculation and post-TOCE acute gastroduo-
denitis was examined. Acute gastroduodenitis was
defined endoscopically as mucosal erosions with or
without haemorrhages (Fig 4). Thirty-six per cent of
patients receiving TOCE were found to develop acute
gastroduodenitis. This was associated with a lower pre-
TOCE mucosal oxygen saturation level in the antrum
and the first part of the duodenum.37
Endoscopic ultrasound
Endoscopic ultrasound is useful for detecting varices.
Varices are imaged within the submucosa and in the
perioesophageal or perigastric soft tissue.38 In the
oesophagus, EUS does not appear to be superior to
endoscopy in the detection of oesophageal varices. On
the other hand, EUS is invaluable in differentiating
gastric varices from submucosal tumours and promi-
nent gastric folds. For submucosal malignancy such
as linitis plastica or infiltrating lymphoma, there is wide
infiltration and distortion of the third and fourth mu-
cosal layers, whereas gastric mucosal folds are
limited to the mucosal layers. In addition, the role
of EUS in determining whether or not varices are ob-
literated is under evaluation.
Endoscopic ultrasound has been shown to be
at least as sensitive and specific for the diagnosis
of choledocholithiasis as endoscopic retrograde
cholangiography (ERCP)39 and EUS is a very safe
procedure with a complication rate of approximately
0.05%. The major complication is perforation,
which is related to the relatively large diameter and
stiffness of the endoscope used. The greatest risk
of perforation exists when an ultrasound endoscope
is passed through a malignant oesophageal stricture
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in an attempt to achieve accurate staging. In addi-
tion to perforation, heavy bleeding after EUS has
been reported.
Endoscopic retrograde
cholangiopancreatography
Endoscopic retrograde cholangiopancreatography
plays a major role in the diagnosis of recurrent pyo-
genic cholangitis (RPC).40 This is a condition in which
there is a primary bacterial cholangitis, characterised
clinically by recurrent attacks of fever, abdominal pain,
and jaundice.41 The extrahepatic and intrahepatic ducts
frequently show dilatation and stricture, and may con-
tain calculi, debris (mainly bile pigments, shed epi-
thelial cells, and mixed exudates), and sometimes pus.42
Endoscopic sphincterotomy is a safe and effective form
of treatment in patients with RPC whose calculi are
confined to the common bile duct.43 Endoscopic retro-
grade cholangiopancreato-graphy is invaluable in di-
agnosing biliary tract obstruction that may aggravate
underlying liver disease. Therapeutic procedures to
relieve biliary obstruction, such as endoscopic sphinc-
terotomy, insertion of nasobiliary catheters, stenting,
stone extraction, and balloon dilatation of biliary stric-
ture can all be performed endoscopically.44 Endoscopic
retrograde cholangiopancreatography is also important
in diagnosing primary sclerosing cholangitis. This con-
dition gives rise to diffuse multifocal short
strictures with patchy distribution throughout the liver
and the large bile ducts. There is usually some degree
of focal dilatation, which gives a characteristic beaded
appearance. In addition, there might be slight irregu-
larities in the walls of the intrahepatic ducts. Primary
biliary cirrhosis may cause cholangiographic appear-
ances similar to those of primary sclerosing cholangi-
tis. However, the stricture is less pronounced and is
more peripheral in location and the extrahepatic ducts
are usually not affected. In patients with cirrhosis, the
radiographic appearance is often abnormal with a wide
spectrum of ductal abnormalities that are not diagnos-
tic of the underlying cause of cirrhosis and are rela-
tively non-specific.
Laparoscopy
Laparoscopy involves the creation of a pneumo-peri-
toneum via a small incision through the abdominal
wall, followed by the insertion of a fibre-optic laparo-
scope into the peritoneal cavity. This procedure can
be performed safely under local anaesthesia and seda-
tion.45 It is a well tolerated procedure that can be read-
ily performed in the endoscopy suite and allows direct
visualisation of the peritoneal cavity and its contents.
Biopsies can be performed using a Silverman or Tru-
cut needle.
The use of laparoscopy in the evaluation of liver
disease has recently gained popularity in European
countries and in Japan. In the investigation of patients
with chronic liver disease, it is more accurate than his-
tology alone in staging the severity of disease and adds
valuable prognostic information. In patients with fo-
cal liver disease, it has a high degree of sensitivity and
this is likely to increase with technological advances,
such as laparoscopy ultrasound.46-48 Recently, its ap-
plication has been expanded by the introduction of a
fibre-optic laparoscope that has a diameter of only 2
mm.
Complications and contraindications
The complication rate of laparoscopy is low. Most com-
plications are related to the biopsy rather than to the
laparoscopic procedure. Overall, the mortality rate of
diagnostic laparoscopy is between 0.02% and 0.05%,
which is similar to that for a percutaneous liver bi-
opsy. Laparoscopic complications, other than those
related to the liver biopsy, include bleeding from the
abdominal wall stab site, pneumo-omentum, surgical
emphysema, and infection.
Contraindications can be divided into absolute and
relative ones. Absolute contraindications include an
uncooperative patient, abdominal wall sepsis, and
gross coagulopathy. Relative ones comprise patients
with marked obesity, a large ventral hernia, previous
right upper quadrant surgery, poor cardiorespiratory
function, or ascites.
Using laparoscopy in hepatology
Laparoscopy can be used in hepatology to stage chronic
liver disease, diagnose non-cirrhotic liver disease, iden-
tify focal lesions, and to diagnose peritoneal disease.
Diagnostic laparoscopy is useful in identifying and
providing prognostic information of cirrhosis. Histo-
logical examination fails or is inconclusive in diag-
nosing cirrhosis in approximately 10% of cirrhotic
patients, principally because the small biopsy size may
miss diseased areas in patients with macronodular cir-
rhosis. Laparoscopy, on the other hand, approaches
100% sensitivity and 90% specificity in the diagnosis
of cirrhosis.49
Macronodular changes are easier to identify than
micronodular changes in which disruption of light
reflex may be a valuable clue. Close inspection of the
anterior edge is important as early cirrhosis may be re-
vealed by irregularity of the normally smooth convex
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edge. In addition, left lobe hypertrophy compared with
the right, the completeness of the regenerating nodule,
the presence of splenomegaly, and the development of
lymphatic cysts on the liver surface are all predictors of
reduced survival.50 It is hoped that further progress will
be made in this area, perhaps by means of image analy-
sis, which might allow volume measurements to be cal-
culated.
The accuracy of laparoscopy in the diagnosis of non-
cirrhotic liver disease has been studied less, but is prob-
ably as accurate as histology. In a recent study,
laparoscopy was compared with histology and showed a
sensitivity and specificity for detecting fatty change of
96.4% and 100%, for fibrosis of 100% and 95%, and for
in-flammatory activity of 94% and 95%, respectively.51
One of the great advantages of modern laparoscopy
is its high level of resolution. Lesions of only 1 mm or 2
mm can be readily recognised and this represents a dis-
tinct advantage over both ultrasonography and computed
tomography (CT) scanning. Malignancy has been iden-
tified by laparoscopy in up to 30% to 50% of patients
thought to have hepatic or peritoneal malignancy but who
have normal ultrasound or CT scans. In addition,
laparoscopy can help to confirm the presence of focal
lesions identified by conventional ultrasound or CT scans.
Another advantage of laparoscopy in identifying focal
lesions is the recognition of features not apparent using
other techniques.52 For example, laparoscopy can locate
yellow nodules undergoing fatty change in cirrhotic
livers, an early indicator of HCC.
Laparoscopy can identify novel features in the in-
vestigation of non-malignant disease. It has been re-
ported that dark, red, patchy markings on the liver
surface of patients with chronic active hepatitis B sig-
nifies reduced hepatitis B replication.53 Laparoscopy
ultrasound has also improved the detection rate of oc-
cult liver lesions, cysts, tumours, various benign focal
hypoplasias, and granulomata.54 As advances in tech-
nology allow the diameter of instruments to be reduced,
it is likely that laparoscopy ultrasound will be per-
formed without general anaesthesia. In addition to the
detection of small lesions, laparoscopy is invaluable
in staging lymphoma.55,56 Two other situations in which
laparoscopy has been reported as useful is in the in-
vestigation of ascites and in patients with pyrexia of
unknown origin. In these situations, advances in other
non-invasive diagnostic tools have reduced the require-
ments for laparoscopy. However, when the cause of
ascites or pyrexia of unknown origin is unclear, de-
spite extensive investigation, laparoscopy is still a valu-
able diagnostic procedure.
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